Schedule 13G ownership disclosure

Kiniksa Pharmaceuticals, Ltd.

Security class unavailable

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000897101-18-000644
Form type
SC 13G
Filer
Desnick Robert
CIK
CIK 1745601
Filed
Jul 19, 2018
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub